Notice of Change to Eligibility Information and Application Instructions in RFA-RM-20-005 4DN Organization and Function in Human Health and Disease (U01 Clinical Trial Not Allowed)

Notice Number: NOT-RM-20-006

Key Dates
Release Date: December 5, 2019

Related Announcements
RFA-RM-20-005

Issued by
Office of Strategic Coordination (Common Fund)

Purpose

The dual purpose of this Notice is: to modify the list on Section III. Eligibility Information, under the heading 1. Eligible Applicants, Eligible Organizations, subheading “Governments” to include the NIH intramural Program; this changes the relevant listing from “Eligible Agencies of the Federal Government” to “Eligible Agencies of the Federal Government including the NIH Intramural Program”, and to add language about the Applications Involving the NIH Intramural Research Program.

Applications Involving the NIH Intramural Research Program

The requests by NIH intramural scientists will be limited to the incremental costs required for participation. As such, these requests will not include any salary and related fringe benefits for career, career conditional or other Federal employees (civilian or uniformed service) with permanent appointments under existing position ceilings or any costs related to administrative or facilities support (equivalent to Facilities and Administrative or F&A costs). These costs may include salary for staff to be specifically hired under a temporary appointment for the project, consultant costs, equipment, supplies, travel, and other items typically listed under Other Expenses. Applicants should indicate the number of person-months devoted to the project, even if no funds are requested for salary and fringe benefits.

If selected, appropriate funding will be provided by the Common Fund through the NIH Intramural Program. NIH intramural scientists will participate in this program as PD/PIs in accord with the Terms and Conditions provided in this FOA. Intellectual property will be managed in accord with established policy of the NIH in compliance with Executive Order 10096, as amended, 45 CFR Part 7; patent rights for inventions developed in NIH facilities are NIH property unless NIH waives its rights.

Should an extramural application include the collaboration with an intramural scientist, no funds for the support of the intramural scientist may be requested in the application. The intramural scientist may submit a separate request for intramural funding as described above.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

John Satterlee, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1020
Email: satterleej@nida.nih.gov